Capsaicin, a component of red peppers, induces expression of androgen receptor via PI3K and MAPK pathways in prostate LNCaP cells

FEBS Letters

Volumn 583, Issue 1, 2009, Pages 141-147

  Malagarie Cazenave, Sophie ^a   Olea Herrero, Nuria ^a   Vara, Diana ^a   Díaz Laviada, Inés ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Androgen receptor; Capsaicin; Ceramide; LNCaP cells; Prostate cancer

Indexed keywords

4 CHLORO N (3 METHOXYPHENYL)CINNAMAMIDE; ANDROGEN RECEPTOR; CAPSAICIN; CAPSAZEPINE; CERAMIDE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ARTICLE; CANCER CELL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANILIDES; CAPSAICIN; CAPSICUM; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CINNAMATES; DITERPENES; GENE SILENCING; HUMANS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PROSTATE; RECEPTORS, ANDROGEN; RNA, SMALL INTERFERING; TRPV CATION CHANNELS;

CAPSICUM ANNUUM VAR. ANNUUM;

EID: 57749188229     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.11.038     Document Type: Article

References (37)

1. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol. Rev. 43 (1991) 143-201
2. Knotkova H., Pappagallo M., and Szallasi A. Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival?. Clin. J. Pain 24 (2008) 142-154
3. Gunthorpe M.J., and Szallasi A. Peripheral TRPV1 receptors as targets for drug development: new molecules and mechanisms. Curr. Pharm. Des. 14 (2008) 32-41
4. Suri A., and Szallasi A. The emerging role of TRPV1 in diabetes and obesity. Trends Pharmacol. Sci. 29 (2008) 29-36
5. Roufogalis, B.D. and Dedov, V.N. (2000) in: Crubasik S. and Roufogalis, B.D. (Eds.) Herbal Medicinal Products for the Treatment of Pain, Australia, pp. 94-98.
6. Sterner O., and Szallasi A. Novel natural vanilloid receptor agonists: new therapeutic targets for drug development. Trends Pharmacol. Sci. 20 (1999) 459-465
7. Surh Y. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat. Res. 428 (1999) 305-327
8. Tominaga M., and Tominaga T. Structure and function of TRPV1. Pflug. Arch. 451 (2005) 143-150
9. Kim Y.M., Hwang J.T., Kwak D.W., Lee Y.K., and Park O.J. Involvement of AMPK signaling cascade in capsaicin-induced apoptosis of HT-29 colon cancer cells. Ann. NY Acad. Sci. 1095 (2007) 496-503
10. Chow J., Norng M., Zhang J., and Chai J. TRPV6 mediates capsaicin-induced apoptosis in gastric cancer cells - mechanisms behind a possible new "hot" cancer treatment. Biochim. Biophys. Acta 1773 (2007) 565-576
11. Wu C.C., Lin J.P., Yang J.S., Chou S.T., Chen S.C., Lin Y.T., Lin H.L., and Chung J.G. Capsaicin induced cell cycle arrest and apoptosis in human esophagus epidermoid carcinoma CE 81T/VGH cells through the elevation of intracellular reactive oxygen species and Ca2+ productions and caspase-3 activation. Mutat. Res. 601 (2006) 71-82
12. Athanasiou A., et al. Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: how vanilloids cause non-vanilloid receptor mediated cell death. Biochem. Biophys. Res. Commun. 354 (2007) 50-55
13. Harada N., Okajima K., Kurihara H., and Nakagata N. Stimulation of sensory neurons by capsaicin increases tissue levels of IGF-I, thereby reducing reperfusion-induced apoptosis in mice. Neuropharmacology 52 (2007) 1303-1311
14. Matucci-Cerinic M., Marabini S., Jantsch S., Cagnoni M., and Partsch G. Effects of capsaicin on the metabolism of rheumatoid arthritis synoviocytes in vitro. Ann. Rheum. Dis. 49 (1990) 598-602
15. Verschoyle R.D., Steward W.P., and Gescher A.J. Putative cancer chemopreventive agents of dietary origin-how safe are they?. Nutr. Cancer 59 (2007) 152-162
16. Surh Y.J., and Lee S.S. Capsaicin in hot chili pepper: carcinogen, co-carcinogen or anticarcinogen?. Food Chem. Toxicol. 34 (1996) 313-316
17. Sanchez A.M., Sanchez M.G., Malagarie-Cazenave S., Olea N., and Diaz-Laviada I. Induction of apoptosis in prostate tumor PC-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin. Apoptosis 11 (2006) 89-99
18. Sanchez A.M., Malagarie-Cazenave S., Olea N., Vara D., Chiloeches A., and Diaz-Laviada I. Apoptosis induced by capsaicin in prostate PC-3 cells involves ceramide accumulation, neutral sphingomyelinase, and JNK activation. Apoptosis 12 (2007) 2013-2024
19. Zilliacus J., Wright A.P., Carlstedt-Duke J., and Gustafsson J.A. Structural determinants of DNA-binding specificity by steroid receptors. Mol. Endocrinol. 9 (1995) 389-400
20. Malagarie-Cazenave S., et al. Role of FAN in tumor necrosis factor-alpha and lipopolysaccharide-induced interleukin-6 secretion and lethality in d-galactosamine-sensitized mice. J. Biol. Chem. 279 (2004) 18648-18655
21. Messeguer A., Planells-Cases R., and Ferrer-Montiel A. Physiology and pharmacology of the vanilloid receptor. Curr. Neuropharmacol. 4 (2006) 1-15
22. Chuang H.H., Neuhausser W.M., and Julius D. The super-cooling agent icilin reveals a mechanism of coincidence detection by a temperature-sensitive TRP channel. Neuron 43 (2004) 859-869
23. De Petrocellis L., Starowicz K., Moriello A.S., Vivese M., Orlando P., and Di Marzo V. Regulation of transient receptor potential channels of melastatin type 8 (TRPM8): effect of cAMP, cannabinoid CB(1) receptors and endovanilloids. Exp. Cell Res. 313 (2007) 1911-1920
24. Sanchez M.G., Sanchez A.M., Collado B., Malagarie-Cazenave S., Olea N., Carmena M.J., Prieto J.C., and Diaz-Laviada I.I. Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue. Eur. J. Pharmacol. 515 (2005) 20-27
25. Levade T., Malagarie-Cazenave S., Gouaze V., Segui B., Tardy C., Betito S., Andrieu-Abadie N., and Cuvillier O. Ceramide in apoptosis: a revisited role. Neurochem. Res. 27 (2002) 601-607
26. Tang H.B., and Nakata Y. The activation of transient receptor potential vanilloid receptor subtype 1 by capsaicin without extracellular Ca(2+) is involved in the mechanism of distinct substance P release in cultured rat dorsal root ganglion neurons. Naunyn Schmiedebergs Arch. Pharmacol. 377 (2008) 325-332
27. Joung E.J., Li M.H., Lee H.G., Somparn N., Jung Y.S., Na H.K., Kim S.H., Cha Y.N., and Surh Y.J. Capsaicin induces heme oxygenase-1 expression in HepG2 cells via activation of PI3K-Nrf2 signaling: NAD(P)H:quinone oxidoreductase as a potential target. Antioxid. Redox Signal 9 (2007) 2087-2098
28. Sun R.Q., Tu Y.J., Yan J.Y., and Willis W.D. Activation of protein kinase B/Akt signaling pathway contributes to mechanical hypersensitivity induced by capsaicin. Pain 120 (2006) 86-96
29. Sun R., Yan J., and Willis W.D. Activation of protein kinase B/Akt in the periphery contributes to pain behavior induced by capsaicin in rats. Neuroscience 144 (2007) 286-294
30. Xu J.T., Tu H.Y., Xin W.J., Liu X.G., Zhang G.H., and Zhai C.H. Activation of phosphatidylinositol 3-kinase and protein kinase B/Akt in dorsal root ganglia and spinal cord contributes to the neuropathic pain induced by spinal nerve ligation in rats. Exp. Neurol. 206 (2007) 269-279
31. Wang Y., Kreisberg J.I., and Ghosh P.M. Cross-talk between the androgen receptor and the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer. Curr. Cancer Drug Targets 7 (2007) 591-604
32. Mori A., Lehmann S., O'Kelly J., Kumagai T., Desmond J.C., Pervan M., McBride W.H., Kizaki M., and Koeffler H.P. Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. Cancer Res. 66 (2006) 3222-3229
33. Melck D., De Petrocellis L., Orlando P., Bisogno T., Laezza C., Bifulco M., and Di Marzo V. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Endocrinology 141 (2000) 118-126
34. Ferrer-Montiel A., Garcia-Martinez C., Morenilla-Palao C., Garcia-Sanz N., Fernandez-Carvajal A., Fernandez-Ballester G., and Planells-Cases R. Molecular architecture of the vanilloid receptor. Insights for drug design. Eur. J. Biochem. 271 (2004) 1820-1826
35. Zhang L., and Barritt G.J. Evidence that TRPM8 is an androgen-dependent Ca2+ channel required for the survival of prostate cancer cells. Cancer Res. 64 (2004) 8365-8373
36. Prevarskaya N., Flourakis M., Bidaux G., Thebault S., and Skryma R. Differential role of TRP channels in prostate cancer. Biochem. Soc. Trans. 35 (2007) 133-135
37. Birder L.A. TRPs in bladder diseases. Biochim. Biophys. Acta 1772 (2007) 879-884